Molecular Partners Competitors and Similar CompaniesClear all
Brii Biosciences's competitors and similar companies include Design Therapeutics and Abliva.
 Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. |  Design Therapeutics Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | |
Founding Date | Founding Date 2018 | Founding Date 2017 | Founding Date 2000 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Carlsbad, US HQ | Locations Lund, SE HQ |
Employees | Employees 8510% decrease | Employees 54 | Employees 950% increase |
Financial | |||
Net income | Net income N/A | Net income ($69.8m) (FY, 2025) | Net income (kr90m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 415m | Total funding raised $ 45m | Total funding raised $ 10.8m |
For sources of this data, please see the company profile
View Company Profiles
Design Therapeutics
HQ
Carlsbad, US
Employees
54
Design Therapeutics is a biopharmaceutical company engaged the research and development of small-molecule gene targeted chimera therapeutic candidates.
View companyAbliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View company